These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 22578942

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM.
    Clin Infect Dis; 2009 Jun 15; 48(12):1695-703. PubMed ID: 19441981
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov 15; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ, PATH Alliance.
    Diagn Microbiol Infect Dis; 2009 Jun 15; 64(2):152-7. PubMed ID: 19376667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May 15; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of Candida osteoarticular infections with limited duration of antifungal therapy and orthopedic surgical intervention.
    Miller AO, Gamaletsou MN, Henry MW, Al-Hafez L, Hussain K, Sipsas NV, Kontoyiannis DP, Roilides E, Brause BD, Walsh TJ.
    Infect Dis (Lond); 2015 Mar 15; 47(3):144-9. PubMed ID: 25539148
    [Abstract] [Full Text] [Related]

  • 13. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M, Celebi S.
    Expert Rev Anti Infect Ther; 2011 Oct 15; 9(10):923-40. PubMed ID: 21973304
    [Abstract] [Full Text] [Related]

  • 14. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Nov 15; 68(3):278-83. PubMed ID: 20846808
    [Abstract] [Full Text] [Related]

  • 15. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.
    J Antimicrob Chemother; 2008 Dec 15; 62(6):1379-85. PubMed ID: 18782778
    [Abstract] [Full Text] [Related]

  • 16. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
    Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, Ellis DH, Morrissey CO, Chen SC, Australian Candidemia Study, Australasian Society for Infectious Diseases.
    J Antimicrob Chemother; 2010 May 15; 65(5):1042-51. PubMed ID: 20202987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May 15; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

  • 19. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E.
    Mikrobiyol Bul; 2010 Oct 15; 44(4):593-603. PubMed ID: 21063972
    [Abstract] [Full Text] [Related]

  • 20. Ocular manifestations of candidemia.
    Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ.
    Clin Infect Dis; 2011 Aug 01; 53(3):262-8. PubMed ID: 21765074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.